These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17015582)

  • 1. The physical, emotional, and financial trauma incurred by infants and their families when an existing condition is not detected by newborn screening.
    Leight KR
    Pediatrics; 2006 Oct; 118(4):1801-2; author reply 1802. PubMed ID: 17015582
    [No Abstract]   [Full Text] [Related]  

  • 2. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
    Varness TS; Allen DB; Hoffman GL
    J Pediatr; 2005 Oct; 147(4):493-8. PubMed ID: 16227036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening for congenital adrenal hyperplasia in Wisconsin.
    Allen DB
    Wis Med J; 1993 Feb; 92(2):75-8. PubMed ID: 8451862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanded newborn screening for biochemical disorders: the effect of a false-positive result.
    Gurian EA; Kinnamon DD; Henry JJ; Waisbren SE
    Pediatrics; 2006 Jun; 117(6):1915-21. PubMed ID: 16740831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cases of congenital adrenal hyperplasia missed by newborn screening in Minnesota.
    Sarafoglou K; Banks K; Kyllo J; Pittock S; Thomas W
    JAMA; 2012 Jun; 307(22):2371-4. PubMed ID: 22692165
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of neonatal screening for congenital adrenal hyperplasia.
    Honour JW; Torresani T
    Horm Res; 2001; 55(4):206-11. PubMed ID: 11598376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving neonatal screening for congenital adrenal hyperplasia.
    Speiser PW
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3685-6. PubMed ID: 15292288
    [No Abstract]   [Full Text] [Related]  

  • 8. [The grey realities of population screening].
    Coste J; Carel JC; Autier P
    Rev Epidemiol Sante Publique; 2012 Jun; 60(3):163-5. PubMed ID: 22682096
    [No Abstract]   [Full Text] [Related]  

  • 9. Congenital adrenal hyperplasia: an endocrine disorder with neonatal onset.
    Stokowski L
    Crit Care Nurs Clin North Am; 2009 Jun; 21(2):195-212. PubMed ID: 19460664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update: newborn screening for endocrinopathies.
    Pass KA; Neto EC
    Endocrinol Metab Clin North Am; 2009 Dec; 38(4):827-37. PubMed ID: 19944295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technical report: congenital adrenal hyperplasia. Section on Endocrinology and Committee on Genetics.
    Pediatrics; 2000 Dec; 106(6):1511-8. PubMed ID: 11099616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
    Fingerhut R
    Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital adrenal hyperplasia and violation of newborn screening procedures.
    Odajima H; Hosono S; Kayama K; Yoshikawa K; Takahashi S
    Pediatr Int; 2017 Oct; 59(10):1107-1108. PubMed ID: 28960615
    [No Abstract]   [Full Text] [Related]  

  • 14. How many deaths can be prevented by newborn screening for congenital adrenal hyperplasia?
    Grosse SD; Van Vliet G
    Horm Res; 2007; 67(6):284-91. PubMed ID: 17199092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False positive newborn screening results are not always benign.
    Morrison DR; Clayton EW
    Public Health Genomics; 2011; 14(3):173-7. PubMed ID: 21178328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional sensitivity data for newborn screening for congenital adrenal hyperplasia in Wisconsin.
    Varness TS; Allen DB; Hoffman GL
    J Pediatr; 2006 Sep; 149(3):427-8. PubMed ID: 16939770
    [No Abstract]   [Full Text] [Related]  

  • 17. Back to basics: early diagnosis and compliance improve final height outcome in congenital adrenal hyperplasia.
    Schwartz RP
    J Pediatr; 2001 Jan; 138(1):3-5. PubMed ID: 11148504
    [No Abstract]   [Full Text] [Related]  

  • 18. Analyzing the cost of neonatal screening for congenital adrenal hyperplasia.
    Brosnan CA; Brosnan PG; Swint JM
    Pediatrics; 2001 May; 107(5):1238. PubMed ID: 11388323
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluating the accuracy of Malformations Surveillance Program in detecting virilization due to congenital adrenal hyperplasia.
    Travitz J; Westgate MN; Larson C; Holmes LB
    Congenit Anom (Kyoto); 2005 Mar; 45(1):1-4. PubMed ID: 15737123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on 'How many deaths can be prevented by newborn screening for congenital adrenal hyperplasia?' by Grosse and Van Vliet, Hormone Research, 2007;67:284-291.
    Leight KR
    Horm Res; 2007; 68(4):195; author reply 203. PubMed ID: 17389810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.